Antony Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Antony Gao has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Paul Kenneth Witting
Redox Biology Group, Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney
3 shared publications - Angie L. Schroder
Redox Biology Group, Discipline of Pathology, Faculty of Medicine and Health, Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia
2 shared publications - Fairooj N. Rashid
Sydney Medical School (F.N.R., C.H., A.G., J.J.H.C., P.B.), University of Sydney, Sydney, New South Wales, Australia
2 shared publications - Gulfam Ahmad
Redox Biology Group, Discipline of Pathology, Faculty of Medicine and Health, Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia
2 shared publications - Han Shi
Redox Biology Group, Discipline of Pathology, Faculty of Medicine and Health, Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia
2 shared publications - James J. -H. Chong
Centre for Heart Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia
2 shared publications
Latest Publications
- Open Access
- 16 January 2026
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 138 (2)
Human Hearts Intrinsically Increase Cardiomyocyte Mitosis After Myocardial Infarction
BACKGROUND: Myocardial infarction (MI) is a leading cause of death worldwide and can eliminate up to a third of the cardiomyocytes within the human heart. Although cardiomyocytes undergo mitosis during early development, most cardiomyocytes cease cell cycling soon after birth. In contrast, rodent MI models have shown that cardiomyocytes increase mitosis in response to ischemia; however, this has not been shown in humans. METHODS: Using a unique premortem post-MI human heart, immunostaining, bulk RNA sequencing, proteomics, metabolomics, single-nucleus RNA sequencing and a novel post-MI human biopsy method, we investigated human cardiomyocyte mitosis post-MI. RESULTS: We show that adult human cardiomyocytes exhibit increased mitosis and cytokinesis in response to ischemia. CONCLUSIONS: Future development of therapeutics to enhance this intrinsic mitotic potential could lead to new treatments that reverse heart failure via cardiac regeneration.
- 16 January 2026
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 138 (2)
Open AccessHuman Hearts Intrinsically Increase Cardiomyocyte Mitosis After Myocardial Infarction
BACKGROUND: Myocardial infarction (MI) is a leading cause of death worldwide and can eliminate up to a third of the cardiomyocytes within the human heart. Although cardiomyocytes undergo mitosis during early development, most cardiomyocytes cease cell cycling soon after birth. In contrast, rodent MI models have shown that cardiomyocytes increase mitosis in response to ischemia; however, this has not been shown in humans. METHODS: Using a unique premortem post-MI human heart, immunostaining, bulk RNA sequencing, proteomics, metabolomics, single-nucleus RNA sequencing and a novel post-MI human biopsy method, we investigated human cardiomyocyte mitosis post-MI. RESULTS: We show that adult human cardiomyocytes exhibit increased mitosis and cytokinesis in response to ischemia. CONCLUSIONS: Future development of therapeutics to enhance this intrinsic mitotic potential could lead to new treatments that reverse heart failure via cardiac regeneration.
- Open Access
- 21 January 2025
- Published by Australian Society of Plastic Surgeons in Australasian Journal of Plastic Surgery
- Vol. 8 (1) , 1-6
Spring-assisted cranioplasty for isolated sagittal craniosynostosis: a retrospective review
Introduction: Premature fusion of the sagittal suture is the most common form of non-syndromic single-suture craniosynostosis. Surgical correction in infancy is recommended to normalise skull morphology and allow normal brain development, but the optimal approach is controversial. We present our experience with spring-assisted cranioplasty (SAC) for the management of isolated sagittal craniosynostosis. Methods: A retrospective review of 104 consecutive patients with isolated sagittal craniosynostosis managed with SAC at a tertiary referral craniofacial centre between 2008 and 2021. Results: Mean operative time was 63 minutes for spring insertion and 39 minutes for spring removal. Blood transfusion was required in 52.9 per cent of patients, with a mean total volume of 80.3 mL. The complication rate was 22.1 per cent, with spring exposure in two patients (1.9%) and surgical site infection requiring early spring removal in four patients (3.8%). Mean spring expansion was 2.89 cm anteriorly and 3.12 cm posteriorly. Revision vault expansion was required in four patients (3.8%), due to interval development of other synostosis (n = 2), raised intracranial pressure (n = 1), and interval development of other synostosis with raised intracranial pressure (n = 1). Conclusions: Isolated sagittal craniosynostosis can be safely and effectively managed using SAC, with short operative times and hospital stays, manageable associated complications and acceptable long-term outcomes.
- 21 January 2025
- Published by Australian Society of Plastic Surgeons in Australasian Journal of Plastic Surgery
- Vol. 8 (1) , 1-6
Open AccessSpring-assisted cranioplasty for isolated sagittal craniosynostosis: a retrospective review
Introduction: Premature fusion of the sagittal suture is the most common form of non-syndromic single-suture craniosynostosis. Surgical correction in infancy is recommended to normalise skull morphology and allow normal brain development, but the optimal approach is controversial. We present our experience with spring-assisted cranioplasty (SAC) for the management of isolated sagittal craniosynostosis. Methods: A retrospective review of 104 consecutive patients with isolated sagittal craniosynostosis managed with SAC at a tertiary referral craniofacial centre between 2008 and 2021. Results: Mean operative time was 63 minutes for spring insertion and 39 minutes for spring removal. Blood transfusion was required in 52.9 per cent of patients, with a mean total volume of 80.3 mL. The complication rate was 22.1 per cent, with spring exposure in two patients (1.9%) and surgical site infection requiring early spring removal in four patients (3.8%). Mean spring expansion was 2.89 cm anteriorly and 3.12 cm posteriorly. Revision vault expansion was required in four patients (3.8%), due to interval development of other synostosis (n = 2), raised intracranial pressure (n = 1), and interval development of other synostosis with raised intracranial pressure (n = 1). Conclusions: Isolated sagittal craniosynostosis can be safely and effectively managed using SAC, with short operative times and hospital stays, manageable associated complications and acceptable long-term outcomes.
- Open Access
- 18 July 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (14) , 7863
Cyclic Nitroxide 4-Methoxy-Tempo May Decrease Serum Amyloid A-Mediated Renal Fibrosis and Reorganise Collagen Networks in Aortic Plaque
Acute-phase serum amyloid A (SAA) can disrupt vascular homeostasis and is elevated in subjects with diabetes, cardiovascular disease, and rheumatoid arthritis. Cyclic nitroxides (e.g., Tempo) are a class of piperidines that inhibit oxidative stress and inflammation. This study examined whether 4-methoxy-Tempo (4-MetT) inhibits SAA-mediated vascular and renal dysfunction. Acetylcholine-mediated vascular relaxation and aortic guanosine-3′,5′-cyclic monophosphate (cGMP) levels both diminished in the presence of SAA. 4-MetT dose-dependently restored vascular function with corresponding increases in cGMP. Next, male ApoE-deficient mice were administered a vehicle (control, 100 µL PBS) or recombinant SAA (100 µL, 120 µg/mL) ± 4-MetT (at 15 mg/kg body weight via i.p. injection) with the nitroxide administered before (prophylaxis) or after (therapeutic) SAA. Kidney and hearts were harvested at 4 or 16 weeks post SAA administration. Renal inflammation increased 4 weeks after SAA treatment, as judged by the upregulation of IFN-γ and concomitant increases in iNOS, p38MAPK, and matrix metalloproteinase (MMP) activities and increased renal fibrosis (Picrosirius red staining) in the same kidneys. Aortic root lesions assessed at 16 weeks revealed that SAA enhanced lesion size (vs. control; p < 0.05), with plaque presenting with a diffuse fibrous cap (compared to the corresponding aortic root from control and 4-MetT groups). The extent of renal dysfunction and aortic lesion size was largely unchanged in 4-MetT-supplemented mice, although renal fibrosis diminished at 16 weeks, and aortic lesions presented with redistributed collagen networks. These outcomes indicate that SAA stimulates renal dysfunction through promoting the IFN-γ–iNOS–p38MAPK axis, manifesting as renal damage and enhanced atherosclerotic lesions, while supplementation with 4-MetT only affected some of these pathological changes.
- 18 July 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (14) , 7863
Open AccessCyclic Nitroxide 4-Methoxy-Tempo May Decrease Serum Amyloid A-Mediated Renal Fibrosis and Reorganise Collagen Networks in Aortic Plaque
Acute-phase serum amyloid A (SAA) can disrupt vascular homeostasis and is elevated in subjects with diabetes, cardiovascular disease, and rheumatoid arthritis. Cyclic nitroxides (e.g., Tempo) are a class of piperidines that inhibit oxidative stress and inflammation. This study examined whether 4-methoxy-Tempo (4-MetT) inhibits SAA-mediated vascular and renal dysfunction. Acetylcholine-mediated vascular relaxation and aortic guanosine-3′,5′-cyclic monophosphate (cGMP) levels both diminished in the presence of SAA. 4-MetT dose-dependently restored vascular function with corresponding increases in cGMP. Next, male ApoE-deficient mice were administered a vehicle (control, 100 µL PBS) or recombinant SAA (100 µL, 120 µg/mL) ± 4-MetT (at 15 mg/kg body weight via i.p. injection) with the nitroxide administered before (prophylaxis) or after (therapeutic) SAA. Kidney and hearts were harvested at 4 or 16 weeks post SAA administration. Renal inflammation increased 4 weeks after SAA treatment, as judged by the upregulation of IFN-γ and concomitant increases in iNOS, p38MAPK, and matrix metalloproteinase (MMP) activities and increased renal fibrosis (Picrosirius red staining) in the same kidneys. Aortic root lesions assessed at 16 weeks revealed that SAA enhanced lesion size (vs. control; p < 0.05), with plaque presenting with a diffuse fibrous cap (compared to the corresponding aortic root from control and 4-MetT groups). The extent of renal dysfunction and aortic lesion size was largely unchanged in 4-MetT-supplemented mice, although renal fibrosis diminished at 16 weeks, and aortic lesions presented with redistributed collagen networks. These outcomes indicate that SAA stimulates renal dysfunction through promoting the IFN-γ–iNOS–p38MAPK axis, manifesting as renal damage and enhanced atherosclerotic lesions, while supplementation with 4-MetT only affected some of these pathological changes.
- Open Access
- 7 September 2023
- Published by Springer Nature in Research Square
Human hearts have an intrinsic regenerative potential following myocardial infarction
Myocardial infarction (MI) is a leading cause of death worldwide and can eliminate up to a third of the cardiomyocytes (CMs) within the heart. Several non-human mammalian models and a limited number of human heart studies suggest that CMs can proliferate during early development, but most CMs stop regenerating soon after birth. In contrast, rodent MI models show that CMs increase their regenerative capacity in response to ischemia, however this has not been shown in humans. Using immunostaining, multi-omics and a unique pre-mortem human heart collected 5 days post-MI, we show that adult human CMs exhibit an increased intrinsic regenerative potential in response to ischemia. Furthermore, single nucleus ribonucleic acid sequencing (snRNAseq) reveals the unique gene expression of post-MI proliferative human CMs. Finally, we demonstrate a novel clinical method to safely biopsy peri-ischemic post-MI human heart tissue and provide further evidence of ischemic CM regeneration. Developing a means to enhance this intrinsic CM regenerative potential could lead to novel therapeutics for cardiac injury and heart failure.
- 7 September 2023
- Published by Springer Nature in Research Square
Open AccessHuman hearts have an intrinsic regenerative potential following myocardial infarction
Myocardial infarction (MI) is a leading cause of death worldwide and can eliminate up to a third of the cardiomyocytes (CMs) within the heart. Several non-human mammalian models and a limited number of human heart studies suggest that CMs can proliferate during early development, but most CMs stop regenerating soon after birth. In contrast, rodent MI models show that CMs increase their regenerative capacity in response to ischemia, however this has not been shown in humans. Using immunostaining, multi-omics and a unique pre-mortem human heart collected 5 days post-MI, we show that adult human CMs exhibit an increased intrinsic regenerative potential in response to ischemia. Furthermore, single nucleus ribonucleic acid sequencing (snRNAseq) reveals the unique gene expression of post-MI proliferative human CMs. Finally, we demonstrate a novel clinical method to safely biopsy peri-ischemic post-MI human heart tissue and provide further evidence of ischemic CM regeneration. Developing a means to enhance this intrinsic CM regenerative potential could lead to novel therapeutics for cardiac injury and heart failure.
- Open Access
- 22 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (22) , 12582
Pro-Inflammatory Serum Amyloid a Stimulates Renal Dysfunction and Enhances Atherosclerosis in Apo E-Deficient Mice
Acute serum amyloid A (SAA) is an apolipoprotein that mediates pro-inflammatory and pro-atherogenic pathways. SAA-mediated signalling is diverse and includes canonical and acute immunoregulatory pathways in a range of cell types and organs. This study aimed to further elucidate the roles for SAA in the pathogenesis of vascular and renal dysfunction. Two groups of male ApoE-deficient mice were administered SAA (100 µL, 120 µg/mL) or vehicle control (100 µL PBS) and monitored for 4 or 16 weeks after SAA treatment; tissue was harvested for biochemical and histological analyses at each time point. Under these conditions, SAA administration induced crosstalk between NF-κB and Nrf2 transcriptional factors, leading to downstream induction of pro-inflammatory mediators and antioxidant response elements 4 weeks after SAA administration, respectively. SAA treatment stimulated an upregulation of renal IFN-γ with a concomitant increase in renal levels of p38 MAPK and matrix metalloproteinase (MMP) activities, which is linked to tissue fibrosis. In the kidney of SAA-treated mice, the immunolocalisation of inducible nitric oxide synthase (iNOS) was markedly increased, and this was localised to the parietal epithelial cells lining Bowman’s space within glomeruli, which led to progressive renal fibrosis. Assessment of aortic root lesion at the study endpoint revealed accelerated atherosclerosis formation; animals treated with SAA also showed evidence of a thinned fibrous cap as judged by diffuse collagen staining. Together, this suggests that SAA elicits early renal dysfunction through promoting the IFN-γ-iNOS-p38 MAPK axis that manifests as the fibrosis of renal tissue and enhanced cardiovascular disease.
- 22 November 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (22) , 12582
Open AccessPro-Inflammatory Serum Amyloid a Stimulates Renal Dysfunction and Enhances Atherosclerosis in Apo E-Deficient Mice
Acute serum amyloid A (SAA) is an apolipoprotein that mediates pro-inflammatory and pro-atherogenic pathways. SAA-mediated signalling is diverse and includes canonical and acute immunoregulatory pathways in a range of cell types and organs. This study aimed to further elucidate the roles for SAA in the pathogenesis of vascular and renal dysfunction. Two groups of male ApoE-deficient mice were administered SAA (100 µL, 120 µg/mL) or vehicle control (100 µL PBS) and monitored for 4 or 16 weeks after SAA treatment; tissue was harvested for biochemical and histological analyses at each time point. Under these conditions, SAA administration induced crosstalk between NF-κB and Nrf2 transcriptional factors, leading to downstream induction of pro-inflammatory mediators and antioxidant response elements 4 weeks after SAA administration, respectively. SAA treatment stimulated an upregulation of renal IFN-γ with a concomitant increase in renal levels of p38 MAPK and matrix metalloproteinase (MMP) activities, which is linked to tissue fibrosis. In the kidney of SAA-treated mice, the immunolocalisation of inducible nitric oxide synthase (iNOS) was markedly increased, and this was localised to the parietal epithelial cells lining Bowman’s space within glomeruli, which led to progressive renal fibrosis. Assessment of aortic root lesion at the study endpoint revealed accelerated atherosclerosis formation; animals treated with SAA also showed evidence of a thinned fibrous cap as judged by diffuse collagen staining. Together, this suggests that SAA elicits early renal dysfunction through promoting the IFN-γ-iNOS-p38 MAPK axis that manifests as the fibrosis of renal tissue and enhanced cardiovascular disease.
- 1 October 2020
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 692, 108490
The role of sodium thiocyanate supplementation during dextran sodium sulphate-stimulated experimental colitis
- 1 October 2020
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 692, 108490
The role of sodium thiocyanate supplementation during dextran sodium sulphate-stimulated experimental colitis